Research Study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease
Principal Investigator 
Lynn A. Raymond

Overview

Body Locations and Systems 
Huntington's Disease
ClinicalTrials.gov# 
NCT04102579
Status 
Recruiting
Study Start/End 
Nov 1, 2019 to Nov 1, 2021
Name/Title 
Mike Adurogbangba, Research Coordinator
Phone 
604-822-4872
Purpose of Study 

The purpose of this study is to assess the safety and tolerability of valbenazine for the treatment of chorea associated with Huntington's Disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.